91 related articles for article (PubMed ID: 7143091)
1. Serum myoglobin in primary hypothyroidism and effect of L-thyroxine therapy.
Martino E; Sardano G; Vaudagna G; Bambini G; Breccia M; Motz E; Ciampi M; Baschieri L; Pinchera A
J Nucl Med; 1982 Dec; 23(12):1088-92. PubMed ID: 7143091
[TBL] [Abstract][Full Text] [Related]
2. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
[TBL] [Abstract][Full Text] [Related]
3. IGF-1 and IGFBP in congenital and acquired hypothyroidism after long-term replacement treatment.
Bona G; Rapa A; Boccardo G; Silvestro L; Chiorboli E
Minerva Endocrinol; 1999 Jun; 24(2):51-5. PubMed ID: 10941423
[TBL] [Abstract][Full Text] [Related]
4. IGF-1 and IGFBP-3 in congenital and acquired hypothyroidism after long-term replacement treatment.
Bona G; Rapa A; Boccardo G; Silvestro L; Chiorboli E
Panminerva Med; 1998 Jun; 40(2):103-6. PubMed ID: 9689829
[TBL] [Abstract][Full Text] [Related]
5. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
[TBL] [Abstract][Full Text] [Related]
6. Reevaluation of patients on thyroxine therapy.
Rizzolo PJ; Porr D; Fisher PC
J Fam Pract; 1986 Mar; 22(3):241-4. PubMed ID: 3950553
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone indices during illness in six hypothyroid subjects rendered euthyroid with levothyroxine therapy.
Wadwekar D; Kabadi UM
Exp Clin Endocrinol Diabetes; 2004 Jul; 112(7):373-7. PubMed ID: 15239022
[TBL] [Abstract][Full Text] [Related]
8. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
Iqbal A; Jorde R; Figenschau Y
J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
[TBL] [Abstract][Full Text] [Related]
9. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
[TBL] [Abstract][Full Text] [Related]
10. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
Schmid C; Zwimpfer C; Brändle M; Krayenbühl PA; Zapf J; Wiesli P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519
[TBL] [Abstract][Full Text] [Related]
11. Serum myoglobin level in altered thyroid states.
Kasai K
J Clin Endocrinol Metab; 1979 Jan; 48(1):1-4. PubMed ID: 422690
[TBL] [Abstract][Full Text] [Related]
12. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs.
Peterson ME; Melián C; Nichols R
J Am Vet Med Assoc; 1997 Dec; 211(11):1396-402. PubMed ID: 9394888
[TBL] [Abstract][Full Text] [Related]
13. [Serum levels od D-thyroxine in euthyroidism and hypothyroidism (author's transl)].
Leb G; Budna KW; Sommersgutter M; Goebel R; Lankmayr EP; Passath A; Knapp G
Acta Med Austriaca; 1981; 8(3):71-4. PubMed ID: 7270017
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of hypothyroidism with L-thyroxine].
Zgliczyńska-Widłak J
Pol Tyg Lek; 1993 Jul 5-12; 48(27-28):605-8. PubMed ID: 8090652
[TBL] [Abstract][Full Text] [Related]
15. Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy.
Saravanan P; Siddique H; Simmons DJ; Greenwood R; Dayan CM
Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):261-7. PubMed ID: 17479444
[TBL] [Abstract][Full Text] [Related]
16. Management of overt and subclinical hypothyroidism. Factors influencing L-thyroxine dosage.
Rezzónico JN; Pusiol E; Saravi FD; Rezzónico M; Bossa N
Medicina (B Aires); 1999; 59(6):698-704. PubMed ID: 10752211
[TBL] [Abstract][Full Text] [Related]
17. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment.
Parle JV; Franklyn JA; Cross KW; Jones SR; Sheppard MC
Br J Gen Pract; 1993 Mar; 43(368):107-9. PubMed ID: 8323787
[TBL] [Abstract][Full Text] [Related]
18. [Changes in plasma concentrations of osteoprotegerin before and after levothyroxine replacement therapy in hypothyroid patients].
Xiang GD; Sun HL; Zhao LS; Hou J; Yue L
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2121-5. PubMed ID: 17988532
[TBL] [Abstract][Full Text] [Related]
19. Effect of L-thyroxine treatment on left ventricular function in subclinical hypothyroidism.
Franzoni F; Galetta F; Fallahi P; Tocchini L; Merico G; Braccini L; Rossi M; Carpi A; Antonelli A; Santoro G
Biomed Pharmacother; 2006 Sep; 60(8):431-6. PubMed ID: 16935462
[TBL] [Abstract][Full Text] [Related]
20. Changes in LH and FSH serum pattern following L-T4 withdrawal in L-T4 substituted hypothyroids.
De Luca F; Siracusano MF; Polimeni A; Maiolino MG; Mamì C; Arrigo T
Horm Metab Res; 1987 May; 19(5):230. PubMed ID: 3108132
[No Abstract] [Full Text] [Related]
[Next] [New Search]
